Related Experiment Video
Updated: Aug 16, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Cell biology of diabetic kidney disease
Yashpal S Kanwar1, Shigeru Akagi, Lin Sun
1Department of Pathology, Northwestern University School of Medicine, Chicago, Ill 60611, USA. y-kanwar@northwestern.edu
Abstract:
In large part cellular dysfunctions induced by chronic hyperglycemia are similar in type-1 and -2 diabetes. In both instances chronic hyperglycemia induces injury to a multitude of organs by affecting various target cells. The cells affected may include those derived from of epithelial or mesenchymal progenitors; and at times hyperglycemia may induce phenotypic changes with epithelial-mesenchymal transformation. In the majority of target cells the high-glucose ambience activates various intracellular pathways that are similar except for minor exceptions that are related to the selective expression of various molecules in a given cell type. Keeping in perspective a common paradigm applicable to most of the cells, a brief discussion of different hyperglycemia-induced cellular events pertaining to various pathways is described in this review. They include fluxes of glucose intermediaries in various cellular metabolic pathways, generation of advanced glycation end products (AGEs) and their extra- and intracellular effects, the role of protein kinase C, transforming growth factor-beta, guanosine triphosphate-binding proteins and reactive oxygen species (ROS) in various cellular signaling events. The latter, i.e., ROS, may be central to several intracellular pathways and modulate various events in a reciprocal manner. The information compiled under various subtitles of this synopsis is derived from an enormous amount of literature data summarized in several recent excellent reviews, and thus further reading of them is suggested to gather detailed comprehensive information on each of the subjects.
Insights
Chronic hyperglycemia causes similar cellular dysfunctions in both type-1 and type-2 diabetes, affecting multiple organs. This review details common hyperglycemia-induced cellular events and signaling pathways, including reactive oxygen species (ROS).
Area of Science:
- Cellular Biology
- Diabetic Complications
- Molecular Medicine
Background:
- Chronic hyperglycemia is a hallmark of both type-1 and type-2 diabetes.
- Hyperglycemia-induced cellular dysfunction contributes to multi-organ injury in diabetes.
- Understanding these cellular mechanisms is crucial for developing targeted therapies.
Purpose of the Study:
- To review the common cellular dysfunctions induced by chronic hyperglycemia in diabetes.
- To elucidate the shared intracellular pathways affected by high glucose.
- To highlight the role of specific signaling molecules and reactive oxygen species (ROS) in diabetic cellular injury.
Main Methods:
- Literature review of existing research on hyperglycemia-induced cellular events.
- Analysis of common intracellular pathways activated by high glucose.
- Synthesis of information on advanced glycation end products (AGEs), protein kinase C, TGF-β, and ROS.
Main Results:
- Cellular dysfunctions in type-1 and type-2 diabetes share significant similarities.
- High glucose activates common intracellular pathways, including metabolic fluxes, AGE formation, PKC, TGF-β, and ROS generation.
- Reactive oxygen species (ROS) play a central, reciprocal role in modulating these pathways.
Conclusions:
- A common paradigm exists for hyperglycemia-induced cellular dysfunction across different diabetes types.
- Targeting shared pathways, particularly those involving ROS, may offer therapeutic benefits for diabetic complications.
- Further research into these molecular mechanisms is warranted for comprehensive understanding and treatment development.
Related Concept Videos
Diabetic Nephropathy
Diabetic Retinopathy
Diabetic Ketoacidosis ll: Pathophysiology
Type II Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology